PDx News & Insights
Post categorized under: PDx News & Insights
PathogenDx delivers viral testing solutions for a new era dominated by the global pandemic, and is at the forefront of cannabis, and food testing. We are answering the challenge of individuals, communities and the moment itself, while monitoring the global conversation around pathogen testing to offer even more powerful solutions. Catch up on the latest news driving the future of safe.
- PathogenDx Pivot From COVID-19 Pandemic Shows Benefits of Microarray Technology
The COVID-19 pandemic quickly placed PathogenDx diagnostic testing at the forefront of the response to the worldwide health emergency, and kicked off the development of the D3 ArrayTM technology. PathogenDx has taken our platform, which we used to successfully create COVID tests during the pandemic, to identify urinary tract infections (UTIs).
- CEO Milan Patel Applauds President Biden’s Call For Cannabis Reform
PathogenDx CEO Milan Patel spoke with Forbes to discuss President Biden’s Call For Cannabis Reform In SOTU:
“Rescheduling would trigger federal regulatory agencies to apply national standards to cannabis testing, as opposed to the kaleidoscope of regulations we are currently dealing with across more than 30 states.”
- Automated Sample Prep For Cannabis/Hemp Testing
OctaTM AutoPrep Station is compatible with all of PathogenDx’s AOAC-certified assays – DetectX Combined, QuantX Fungal and QuantX Bacterial—which have been developed to ensure the safety of Cannabis and hemp products for patients and consumers across the U.S.
- Salmonella and E. coli in Cannabis – Milan Patel
Our CEO Milan Patel spoke with Insider and provided some insight on the presence of Salmonella and E. coli in Cannabis, and how businesses can take preventative action. Many who get into Cannabis cultivation aren’t aware of their state’s Cannabis testing regulation requirements for things like levels of mold, pesticides, and bacteria like E. coli.
- PDx Taking the Lead in Arizona Pathogen Testing Innovation
Pathogen testing in the cannabis sector is serious business and Arizona based PDx’s bread and butter, but after success in health diagnostics, we have our eyes set on a more expanded role in the food and environmental testing sectors. Climate change is driving higher temperatures that result in a proliferation of many pathogens. It’s vital to test for these pathogens consistently and obtain quick results before eating infected food or mistakenly tossing uncontaminated products.
- PathogenDx Launches Updated YouTube Channel
Video has always played a pivotal role in how we describe our solutions and communicate with our audience. With YouTube being a key avenue from which we all consume information daily, it is so important to stay engaged with people visually. If you aren’t already subscribed, please do and become part of our growing audience!
- PathogenDx honored by Fast Company 2022 World Changing Ideas Awards
The winners of Fast Company 2022 World Changing Ideas Awards were announced, and PathogenDx has been honored for work in Clinical diagnostics. DetectX-Cv has detected all major Clade Variants, providing results in four hours after receiving a positive sample from any COVID-19 test, running up to 576 samples in a single shift for a fraction of the cost of NGS Sequencing.
- Need for More Stringent Cannabis Lab Testing
CEO Milan Patel shares insights on the current state of microbial Cannabis testing in the US, where we’re falling short, and how we can right the trajectory of the industry by establishing better Cannabis lab testing procedures.
- Talking Hedge Podcast: Cannabis Lab Testing
CEO Milan Patel PathogenDx talks the development of diagnostic solutions to address viral, bacterial and fungal infection or contamination of Cannabis. Patel digs deep into meeting Cannabis state regulations, Cannabis lab testing efficiency, hemp mold testing, hop latent virus, and preventative pathogen testing.
- PathogenDx Strengthens Executive Team; Announces Several New Key Leadership Appointments
PathogenDx is pleased to announce the addition of Board Advisor Paul Glyer, Vice President of Research and Development Ralph Martel, Food & Agriculture Board Advisor Michael Drozd, PhD, and Global Director of Sales Carol Dugas.
“These highly experienced individuals will help us navigate both strategically and tactically as we expand across the different vertical markets with our next-generation diagnostic testing technologies.” – Co-founder and CEO Milan Patel.
Recent Comments